weight loss drugs
Excellus BlueCross BlueShield says GLP-1 drugs for diabetes will remain on formulary, countering reports of a blanket halt. Effective January 1, 2026, three GLP-1s for weight loss—Wegovy, Zepbound, and Saxenda—will be removed from covered lists for certain plans, though members can seek exceptions if prescribers verify criteria. The insurer cites Pharmacy & Therapeutics Committee review […]
Wegovy and Zepbound, which both sell for a list price of more than $1,000 a month, have long been out of reach for people without insurance or whose insurance refused to cover them. Among adults who take the medications, about half say it’s difficult to afford the cost, according to a May 2024 survey by the health policy group […]
GLP-1 drugs, such as Wegovy, Ozempic, and Zepbound, originally developed for diabetes and weight loss, are showing promise in preventing certain cancers. These medications work by regulating hormones, slowing digestion, and reducing hunger, which helps manage obesity—a key risk factor for cancers like breast, colon, liver, and ovarian. Recent studies suggest that GLP-1 drugs can […]
Ozempic, a drug used to treat Type 2 diabetes, is facing a shortage due to its off-label use for weight loss, leading to concerns among diabetic patients who rely on it. Jim Cox, who has Type 2 diabetes, was unable to refill his prescription for Trulicity, a similar medication, due to the shortage. The demand […]
In a prime-time special titled “Shame, Blame and the Weight Loss Revolution,” Oprah Winfrey delved into the evolving landscape of weight loss, spurred by the introduction of drugs like Ozempic and Mounjaro. Acknowledging her own struggles with weight stigma throughout a 25-year public journey, Winfrey aimed to dismantle the shame and judgment surrounding weight and […]
-
Pages
WDKX Holiday Stream